Renalytix Plc Share Price
Stocks
RENX
GB00BYWL4Y04
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
London S.E.
10:05:28 29/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 5.450 GBX | -2.68% |
|
+1.87% | -7.63% |
| 29/10 | Renalytix Plc Reports Earnings Results for the Full Year Ended June 30, 2026 | CI |
| 28/10 | Earnings Flash (RENX.L) Renalytix plc Reports FY26 Revenue $3.0M | MT |
| Market Cap | 1.33Cr 1.19Cr 1.1Cr 99.72L 1.86Cr 127Cr 1.89Cr 13Cr 5.25Cr 66Cr 5Cr 4.9Cr 210.51Cr | P/E 2024 |
-0.45x | P/E 2025 | -1.34x |
|---|---|---|---|---|---|
| Enterprise Value | 1.79Cr 1.61Cr 1.48Cr 1.34Cr 2.51Cr 170.8Cr 2.55Cr 18Cr 7.05Cr 89Cr 6.73Cr 6.59Cr 283.12Cr | EV / Sales 2024 |
1,10,59,330x | EV / Sales 2025 | 1,24,99,418x |
| Free-Float |
81.69% | Yield 2024 * |
-
| Yield 2025 | - |
London S.E.GBX
| Markets | Quality | ||
|---|---|---|---|
London S.E.
| RENX | Delayed | |
OTC Markets
| RENXF | Delayed | |
|
Deutsche Boerse AG
| 2O9 | Delayed | |
|
Börse Stuttgart
| 2O9 | Delayed | |
|
Boerse Muenchen
| 2O9 | Real-time |
Last Transcript: Renalytix Plc
| 1 day | -2.68% | ||
| 1 week | +1.87% | ||
| Current month | -10.66% | ||
| 1 month | -11.38% | ||
| 3 months | +105.66% | ||
| 6 months | +202.78% | ||
| Current year | -7.63% |
| 1 week | 5.15 |  | 6.1 |
| 1 month | 5.1 | | 6.3 |
| Current year | 1.6 | | 6.57 |
| 1 year | 1.6 | | 8.4 |
| 3 years | 1.6 | | 74.9 |
| 5 years | 1.6 | | 909.7 |
| 10 years | 1.6 | | 1,220 |
| Manager | Title | Age | Since |
|---|---|---|---|
James McCullough
CEO | Chief Executive Officer | 58 | 15/03/2018 |
Joel Jung
DFI | Director of Finance/CFO | 68 | 28/05/2024 |
Howard Doran
PSD | President | 65 | 30/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
James McCullough
BRD | Director/Board Member | 58 | 15/03/2018 |
| Chairman | 74 | - | |
Fergus Fleming
BRD | Director/Board Member | 59 | 15/03/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 13/02/26 | Buy | Founder | 250 | 0.0001% | ||
| 13/02/26 | Buy | Chief Financial Officer | 500 | 0.0001% | ||
| 13/02/26 | Buy | Founder | 500 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.68% | +1.87% | -33.94% | -86.38% | 4.5Cr | |
| +0.71% | +2.18% | +27.18% | +64.39% | 26TCr | |
| +1.24% | +1.33% | +9.26% | +26.13% | 16TCr | |
| +1.03% | +4.82% | -17.72% | +73.28% | 15TCr | |
| +0.61% | -4.09% | -57.72% | -13.79% | 6.15TCr | |
| +2.90% | +6.83% | +14.90% | +53.04% | 5.29TCr | |
| +0.70% | +2.83% | -12.22% | -6.48% | 5.28TCr | |
| -2.35% | -3.19% | +6.52% | +63.75% | 5.15TCr | |
| -0.18% | +1.91% | +24.20% | +76.27% | 5.12TCr | |
| +0.67% | +4.94% | +38.77% | +96.14% | 4.69TCr | |
| Average | +0.07% | +1.67% | -0.08% | +34.64% | 8.96TCr | |
| Weighted average by Cap. | +0.38% | +1.41% | +6.54% | +50.96% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.29 2.05 1.89 1.71 3.2 217.98 3.25 22.57 9 114.08 8.59 8.41 361.31 | 3 2.69 2.48 2.24 4.19 285.68 4.26 29.58 11.8 149.51 11.26 11.02 473.54 |
| Net income | -3.35Cr -3Cr -2.76Cr -2.5Cr -4.68Cr -318.59Cr -4.75Cr -33Cr -13Cr -166.74Cr -13Cr -12Cr -528.1Cr | -2.04Cr -1.83Cr -1.69Cr -1.53Cr -2.85Cr -194.26Cr -2.9Cr -20Cr -8.02Cr -101.67Cr -7.66Cr -7.49Cr -322.01Cr |
| Net Debt | 38.55L 34.53L 31.86L 28.83L 53.9L 37Cr 54.78L 3.8Cr 1.52Cr 19Cr 1.45Cr 1.42Cr 61Cr | 46L 41.2L 38.01L 34.4L 64.32L 44Cr 65.36L 4.53Cr 1.81Cr 23Cr 1.73Cr 1.69Cr 73Cr |
Employees
46
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/26/29 | GBX 5.450 | -2.68% | 5,95,142 |
| 28/26/28 | GBX 5.600 | -5.88% | 29,85,462 |
| 27/26/27 | GBX 5.950 | 0.00% | 6,16,207 |
| 26/26/26 | GBX 5.950 | -0.83% | 9,14,935 |
| 23/26/23 | GBX 6.000 | +3.45% | 24,85,415 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- RENX Stock
Select your edition
All financial news and data tailored to specific country editions
